Hi [[ session.user.profile.firstName ]]

A Novel “Thaw and Go” Cell-based Model to Study SLC Transporters

Abstract:
As a key determinant of drug pharmacokinetics, transporter mediated drug-drug interaction has garnered significant attention from the pharmaceutical industry and regulatory authorities. Corning offers a comprehensive list of tools to support drug transporter studies and recently introduced Corning® TransportoCells™ products to support in vitro assessment of drug interaction with SLC transporters. This new model provides a convenient “thaw and go” cell-based model with robust activity and consistent performance. In this webinar, we will provide an overview of Corning TransportoCells products along with applications for in vitro-to-in vivo correlation. Validation data will also be presented for the newly available TransportoCells products, including OATP1A2, OATP2B1, PEPT1, PEPT2, and NTCP.

Presenter Biography:
Dr. Na Li received her B.S degree in Biology from Fudan University, Shanghai, China, and her Ph.D. in Pharmacology from Dartmouth Medical School, Hanover, NH. Her major research focus is on drug transporters, including interspecies differences in hepatobiliary transporters, transporter quantification, and in vitro-to-in vivo extrapolation of drug pharmacokinetics. At Corning, Dr. Li contributes her expertise in in vitro drug transporter technology and its application in drug ADME.
Recorded Feb 24 2015 59 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Na Li, Ph.D.
Presentation preview: A Novel “Thaw and Go” Cell-based Model to Study SLC Transporters

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Organogenesis to Oncogenesis - POSTPONED Mar 23 2021 3:00 pm UTC 45 mins
    Dr. Joseph Regan
    THIS WEBINAR IS POSTPONED UNTIL FURTHER NOTICE

    Organogenesis to Oncogenesis: Modeling Development and Cancer with Organoids
    Organoid cell culture allows mammalian stem cells to differentiate and self-organize into three-dimensional organ-like tissues that reflect the key structural and functional properties of the organs from which they are derived. In addition, organoids can be grown from patient-derived healthy and tumor tissue to provide genetically and phenotypically stable personalized preclinical models. Organoid technologies therefore provide a unique in vitro system in which to study human organ development and cancer.

    In this webinar, Dr. Regan will discuss the use of organoid technologies to study organogenesis and cell fate determination in the postnatal mammary gland. In addition, the use of patient-derived organoids (PDOs) to elucidate the molecular mechanisms that regulate oncogenesis and contribute to tumor heterogeneity in colon cancer will be discussed.

    Presenter:
    Dr. Joseph Regan graduated from The Institute of Cancer Research (University of London, UK) with a Ph.D. in Cell Biology and received postdoctoral training at the Breast Cancer Now Research Centre (London, UK) and the Max Planck Institute for Molecular Genetics (Berlin, Germany). Dr. Regan subsequently worked as a Research Scientist with Bayer AG and the Charité Medical University (Berlin, Germany), where he uses patient-derived organoid models to study cancer stem cells and tumor heterogeneity in colon cancer.
  • がんオルガノイドを用いた抗がん剤の評価 Jul 22 2020 5:00 am UTC 90 mins
    公立大学法人 福島県立医科大学 ふくしま国際医療科学センター  医療-産業トランスレーショナルリサーチセンター セルファクトリー部門 教授 高木 基樹 先生
    がん組織より樹立した長期培養が可能な「がんオルガノイド(F-PDO®)」と「がん細胞株」とのゲノム、遺伝子発現、形態等の違い、がんオルガノイドの培養やアッセイ系構築の難しさ、がん細胞株(平面培養)との抗がん剤の感受性の違いなどについて紹介致します。

    <セミナーのポイント>
    ① がんオルガノイドの樹立と培養
    ② がんオルガノイドの特徴
    ③ がんオルガノイドを用いたアッセイ系構築のポイント
    ④ がんオルガノイドとがん細胞株の抗がん剤感受性の相違
  • ヒトiPS細胞由来高品質心筋細胞の大量作製法の開発と心臓再生医療への応用 Jun 23 2020 6:00 am UTC 90 mins
    慶應義塾大学循環器内科 臓器再生医学寄附講座 特任講師 遠山周吾先生
    ヒトiPS細胞から作製した心筋細胞を用いた再生医療を実現化するにはさまざまな課題を克服する必要があります。本セミナーではその課題を克服するためのアプローチを紹介します。

    ポイント:
    ・ヒトiPS細胞を用いた再生医療における課題について 
    ・ヒトiPS細胞から心筋細胞を大量に作製・回収する方法について
    ・ヒトiPS細胞由来の分化細胞集団から心筋細胞のみを選別する方法について 
    ・ヒトiPS細胞由来の心筋スフェロイドを大量に作製する方法について
  • Identifying and Correcting Common Cell Growth Problems Jun 16 2020 3:00 pm UTC 60 mins
    Dr. Ann E. Rossi
    Cell Culture is a powerful research tool in the life sciences. However, the dynamic nature of living cells can make cell culture a difficult tool to work with in the laboratory, even for the most experience hands. As one of the major suppliers of vessels, media, and sera used in cell culture, Corning Life Sciences often receives calls from anxious customers who are experiencing growth or attachment problems with their cell lines to determine what is responsible for the erratic behavior or loss of their cultures. Identifying the underlying causes of erratic cell behavior, unexplained experimental results, or loss of cultures is often a difficult, time-consuming task. This webinar will help identify and solve common cell culture problems can be traced to the three common problem areas of technique, incubators, and media.

    Dr. Ann E. Rossi graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Prior to joining Corning, Ann worked as a Senior Scientist at ARMGO Pharma, Inc., a small private pharmaceutical company, contributing her expertise in calcium signaling toward developing new assays for the company’s screening cascade. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr. Rossi is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.
  • An optimal Environment Across All Stages of Cell Culture [ENG. VERSION] Jun 11 2020 2:00 pm UTC 30 mins
    Dr. Lindsey Parker
    The Life Sciences Rendez-vous : Bioprocess, Media and Sera - PART 3/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 2 and other languages on our webinar page.

    Media and Sera are crucial components in cell culture – providing nutrition such as inorganic salts, amino acids and vitamins, or growth factors to your cells – and optimal products should be carefully selected.
    This webinar presents an overview of Corning’s media and sera portfolio, and how these may enhance both production and research in bioprocess applications.
    Corning’s media and serum offering includes:
    •Many different formulations of standard media to meet specific applications
    •Serum- free and specialty media
    •Standard and premium origin sera
    •A choice of specialty sera and treatments for optimal cell culture and assay performance
    Join this webinar for an overview of how our media and sera can fit into your workflow.

    About presenters:

    Dr. Lindsey Parker
    Lindsey completed her Ph.D. in Tissue Engineering and Regenerative Medicine at the University of Leeds (UK), validating a bioreactor for the application of mechanical stimuli to MSC. She subsequently joined UCL as an industrial KTP associate, leading clinical research in umbilical cord- derived MSC scale-up in collaboration with a tissue bank. Lindsey is currently a Bioprocess Sales Specialist at Corning, providing specialist support in bioprocess ranges, such as advising on product selection, custom products, and providing training.
  • An optimal Environment Across All Stages of Cell Culture [FR. VERSION] Jun 11 2020 12:00 pm UTC 30 mins
    Dr. Sonia Meconi
    The Life Sciences Rendez-vous : Bioprocess, Media and Sera - PART 3/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 2 and other languages on our webinar page.

    Media and Sera are crucial components in cell culture – providing nutrition such as inorganic salts, amino acids and vitamins, or growth factors to your cells – and optimal products should be carefully selected.
    This webinar presents an overview of Corning’s media and sera portfolio, and how these may enhance both production and research in bioprocess applications.
    Corning’s media and serum offering includes:
    •Many different formulations of standard media to meet specific applications
    •Serum- free and specialty media
    •Standard and premium origin sera
    •A choice of specialty sera and treatments for optimal cell culture and assay performance
    Join this webinar for an overview of how our media and sera can fit into your workflow.

    About presenters:

    Dr. Sonia Meconi
    Sonia’s scientific background covers different fields such as biochemistry, cell biology, and immunology where she obtained a Ph.D., specifically in human infectious diseases working on a daily basis in a biologic level 3 lab. After a post-doctoral fellow and lecturer experience, she took over the head of the R&D and production teams in a small biotech which developed human serological diagnosis assays for infectious and autoimmune diseases. She oversaw pathogens (bacteria and virus) expansion supervision for protein microarray tests. Then, she joined an international company as an Application Specialist for cell culture and purification, creating new cell culture media dedicated to vaccines and cell therapy markets. Now, she joined Corning as Bioprocess Specialist working for different suppliers for the biopharmaceutical industry.
  • An optimal Environment Across All Stages of Cell Culture [GER. VERSION] Jun 10 2020 9:00 am UTC 30 mins
    Dr. Franziska Wienholz
    The Life Sciences Rendez-vous : Bioprocess, Media and Sera - PART 3/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 2 and other languages on our webinar page.

    Media and Sera are crucial components in cell culture – providing nutrition such as inorganic salts, amino acids and vitamins, or growth factors to your cells – and optimal products should be carefully selected.
    This webinar presents an overview of Corning’s media and sera portfolio, and how these may enhance both production and research in bioprocess applications.
    Corning’s media and serum offering includes:
    •Many different formulations of standard media to meet specific applications
    •Serum- free and specialty media
    •Standard and premium origin sera
    •A choice of specialty sera and treatments for optimal cell culture and assay performance
    Join this webinar for an overview of how our media and sera can fit into your workflow.

    About presenters:

    Dr. Franziska Wienholz
    Franziska completed her Ph.D. in Molecular Genetics at the Erasmus MC,The Netherlands, focusing on studying DNA repair and related diseases. During her research, she acquired extensive knowledge on cell culture and patient-derived materials, molecular techniques, and genome editing.
  • Introdução ao Cultivo de Células 3D Jun 9 2020 5:00 pm UTC 60 mins
    Luiz Gustavo Mendes
    Luiz Gustavo Mendes, MSc Field Applications Scientist Corning LifeSciences
  • The Use of Multi-species Organoids Jun 9 2020 2:00 pm UTC 45 mins
    Dr. Valentina Ubertini
    Title: The Use of Multi-species Organoids as a Pre-clinical Screen to Assess Gastrointestinal Toxicity

    The small intestinal organoid model (Sato, et al. 2009) incorporates many of the physiologically relevant features of the in vivo intestinal epithelium, including the presence of all the differentiated cell types and the regenerative progenitor cells. We have validated the organoid model as a screening tool to predict GI toxicity (a common and often severe dose-limiting side effect of chemotherapy) and subsequent mucosal regeneration in four species: mouse, rat, canine and human. Using minimal amounts of drug candidates, these assays are much quicker to perform than in vivo models but have been shown to be highly predictive of the in vivo response. Readouts can include viability and proliferation, but also can include more detailed mechanistic information via gene expression profiling (Next Generation Sequencing), immunohistochemistry, in situ hybridisation (RNAscope), and cytokine profiling.

    Speaker Bio:
    Dr Valentina Ubertini completed her Ph.D. researching the relationship between p53 and the anti-inflammatory cytokine sIL-1Ra at Regina Elena National Cancer Institute, Rome, Italy. She then moved to the Cancer Research UK Manchester Institute to investigate the regulation of inflammatory genes modulating the prostate cancer microenvironment. This experience, using a variety of 3D cell culture models (organoids, spheroids) of both primary cells and cell lines, led her to Epistem, Manchester, UK (a company with a history of providing a range of high quality pre-clinical gastrointestinal research services), to lead a team developing a range of intestinal organoid assays as predictive toxicity screens for novel therapeutics.
  • Producción de Vacunas: Soluciones Corning en Bioproceso Jun 4 2020 7:00 pm UTC 60 mins
    Alfredo Javier Hernandez
    Alfredo Javier Hernandez- Account Manger Corning LifeSciences, maestro en ciencias especializado en biología celular
  • Bioprocess Suspension Solutions - Suspension Workflow [ENG. VERSION] Jun 4 2020 2:00 pm UTC 30 mins
    Constanza Curotto
    The Life Sciences Rendez-vous : Bioprocess, Suspension - PART 2/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 3 and other languages on our webinar page.

    Careful vessel selection at all scales enhances space efficacy, reducing cost and labor hours. Suspension processes play a key role in the biopharmaceuticals market, where suspension cell systems are used to produce antibodies and recombinant proteins. This webinar will provide an overview of Corning's suspension culture portfolio, relevant to both R&D and production scenarios, supported by experimental data from our global applications team.

    About Presenter:

    Constanza Curotto
    After graduating from Biochemistry in the University of Santiago (Chile), Constanza pursued directly a career in the Chilean Vaccine R&D industry, developing as a bioprocess scientist for both bacterial and viral vaccines in the field of animal health, being in charge of scale-up, and tech transfer with manufacturing plants. She furthered developed her career in Belgium as a bioprocess scientist, this time in the field of recombinant protein production, pursuing protocol optimization and scale-up experiments with suspension mammalian cell lines. Constanza is currently a field applications scientist in Corning for the EMEA region, providing customers with in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Bioprocess Suspension Solutions - Suspension Workflow [FR. VERSION] Jun 4 2020 12:00 pm UTC 30 mins
    Dr. Sonia Meconi
    The Life Sciences Rendez-vous : Bioprocess, Suspension - PART 2/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 3 and other languages on our webinar page.

    Careful vessel selection at all scales enhances space efficacy, reducing cost and labor hours. Suspension processes play a key role in the biopharmaceuticals market, where suspension cell systems are used to produce antibodies and recombinant proteins. This webinar will provide an overview of Corning's suspension culture portfolio, relevant to both R&D and production scenarios, supported by experimental data from our global applications team.

    About Presenter:

    Dr. Sonia Meconi
    Sonia’s scientific background covers different fields such as biochemistry, cell biology, and immunology where she obtained a Ph.D., specifically in human infectious diseases working on a daily basis in a biologic level 3 lab. After a post-doctoral fellow and lecturer experience, she took over the head of the R&D and production teams in a small biotech which developed human serological diagnosis assays for infectious and autoimmune diseases. She oversaw pathogens (bacteria and virus) expansion supervision for protein microarray tests. Then, she joined an international company as an Application Specialist for cell culture and purification, creating new cell culture media dedicated to vaccines and cell therapy markets. Now, she joined Corning as Bioprocess Specialist working for different suppliers for the biopharmaceutical industry.
  • Bioprocess Suspension Solutions - Suspension Workflow [GER. VERSION] Jun 4 2020 9:00 am UTC 30 mins
    Dr. Franziska Wienholz
    The Life Sciences Rendez-vous : Bioprocess, Suspension - PART 2/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 1, Part 3 and other languages on our webinar page.

    Careful vessel selection at all scales enhances space efficacy, reducing cost and labor hours. Suspension processes play a key role in the biopharmaceuticals market, where suspension cell systems are used to produce antibodies and recombinant proteins. This webinar will provide an overview of Corning's suspension culture portfolio, relevant to both R&D and production scenarios, supported by experimental data from our global applications team.

    About Presenter:

    Dr. Franziska Wienholz
    Franziska completed her Ph.D. in Molecular Genetics at the Erasmus MC,The Netherlands, focusing on studying DNA repair and related diseases. During her research, she acquired extensive knowledge on cell culture and patient-derived materials, molecular techniques, and genome editing.
  • Organoids Master Class Series: Introduction To & Getting Started With Organoids Jun 3 2020 4:00 pm UTC 60 mins
    Hilary Sherman
    Organoids are radically changing basic research and medicine. These 3D, organ-like collections of cells create innovative approaches to drug development. But how do you get started? That's the subject of our next Organoids Master Class. Our in-house organoids expert will introduce you to organoid technology, explore organoid applications, and reveal culture tips and tricks that will put you on the path to organoid mastery.

    About the Presenter:
    Hilary Sherman is a Senior Scientist in the Corning Life Sciences Applications Lab located in Kennebunk, ME. Hilary has been with Corning Incorporated since 2005 and has worked with a wide variety of cell types including mammalian, insect, primary, stem cells and organoids in a vast array of applications. Her key roles at Corning involve creating technical documents such as protocols and whitepapers as well as providing technical support and training for both the Corning sales force and customers. Hilary received her B.S. degree in Biology from the University of New Hampshire. In the last several years, Hilary has focused on 3D cell culture applications including human organoid culture
  • Qualidade e Acreditação em Laboratórios-Uma Abordagem da Influência da Vidraria Jun 2 2020 5:00 pm UTC 60 mins
    Jeronimo Figueiredo
    Jeronimo Figueiredo, Business Operations - Latin America, Engenheiro Químico, Corning Life Sciences
  • Multiply Your Cells, Not Your Work: How to Upscale Adherent Cells [ENG. VERSION] Recorded: May 28 2020 25 mins
    Constanza Curotto
    The Life Sciences Rendez-vous : Bioprocess, Adherent Cells - PART 1/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 2, Part 3 and other languages on our webinar page.

    Efficient cell scale-up is essential in biologics production; cell type, application, and space dictate the most suitable technology for an application. In this webinar, we will provide an overview of Corning cell culture vessels for adherent cells, and how those can be employed for cell upscaling for bioproduction applications such as vaccine manufacture, upscaling cell therapies, and viral vector production.

    About Presenter:

    Constanza Curotto
    After graduating from the University of Santiago (Chile) studying Biochemistry, Constanza pursued a career in the Chilean Vaccine R&D industry, developing as a bioprocess scientist for both bacterial and viral vaccines.
    She is currently a field applications scientist at Corning Life Sciences for the EMEA region, providing customers with in-depth technical support, presenting seminars, trainings, and assisting customers.
  • Multiply Your Cells, Not Your Work: How to Upscale Adherent Cells [FR. VERSION] Recorded: May 28 2020 28 mins
    Dr. Nicolas André
    The Life Sciences Rendez-vous : Bioprocess, Adherent Cells - PART 1/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 2, Part 3 and other languages on our webinar page.

    Efficient cell scale-up is essential in biologics production; cell type, application, and space dictate the most suitable technology for an application. In this webinar, we will provide an overview of Corning cell culture vessels for adherent cells, and how those can be employed for cell upscaling for bioproduction applications such as vaccine manufacture, upscaling cell therapies, and viral vector production.

    About Presenter:

    Dr. Nicolas André
    Nicolas received his Ph.D. from the University of Frankfurt/Main, in 2006, after studying membrane protein biochemistry at the Max Planck institute of biophysics, under the supervision of Hartmut Michel, 1988 Chemistry Nobel prize. He completed his training with a postdoc research project on membrane protein interaction in CNRS Marseille.
  • Multiply Your Cells, Not Your Work: How to Upscale Adherent Cells [GER. VERSION] Recorded: May 28 2020 27 mins
    Dr. Franziska Wienholz
    The Life Sciences Rendez-vous : Bioprocess, Adherent Cells - PART 1/3.
    Attend our new compact webinars series (30min) in your local language.
    See Part 2, Part 3 and other languages on our webinar page.

    Efficient cell scale-up is essential in biologics production; cell type, application, and space dictate the most suitable technology for an application. In this webinar, we will provide an overview of Corning cell culture vessels for adherent cells, and how those can be employed for cell upscaling for bioproduction applications such as vaccine manufacture, upscaling cell therapies, and viral vector production.

    About Presenter:

    Dr. Franziska Wienholz
    Franziska completed her Ph.D. in Molecular Genetics at the Erasmus MC,The Netherlands, focusing on studying DNA repair and related diseases. During her research, she acquired extensive knowledge on cell culture and patient-derived materials, molecular techniques, and genome editing.
    Franziska joined Corning in 2017 and in her role as Bioprocess Sales Specialist, she is currently supporting customers with technical questions and product selection in the bioprocess field. Additionally, she provides training on Corning applications and solutions in the form of webinars and scientific seminars.
  • Implementation of Functional Diagnostics using Patient-derived Tumor Organoids Recorded: May 21 2020 35 mins
    Dr. Laura Martin
    Full Title: Implementation of Functional Diagnostics and High Throughput Drug Screening of Patient‐Derived Tumor Organoids

    Intro / 3D Cell Culture: From Promise to Reality: 00:00 – 6:52
    Englander Institute for Precision Medicine Drug Discovery Platform: 6:53 – 10:30
    EIPM tumor organoid platform pipeline: 10:31 – 17:28
    EIPM organoid types: 17:29 – 18:59
    High throughput drug screening Core: 19:00 -23:11
    New tools: CRISPR screening: 23:12 – 25:47
    Tumor microenvironment: 25:48 – 28:55
    Human Cancer Model Initiative / summary: 28:56 – 31:45
    Q&A session: 31:46 - 34:59


    Precision medicine aims to match individual patients with the best treatment based on the patients’ tumors biologic and molecular characteristics. As part of the Englander Institute for Precision Medicine at Weill Cornell Medical College, the Tumor Organoid Platform is an active program focused on the development of Next Generation Cancer Models derived from metastatic and primary anatomic sites obtained through biopsies, surgical resections and rapid autopsy procedures. With this platform, they are able to extend their personalized medicine program to include high throughput drug screening, which can be validated through genomic sequencing and both in vivo and in vitro models.
  • セルベースアッセイ用プレートの表面処理技術と利用例 Recorded: May 20 2020 64 mins
    コーニングインターナショナル株式会社 ライフサイエンス事業部 江藤哉子
    コーニングが有する種々の細胞培養表面は、長年に渡り培ってきた技術とノウハウの蓄積を元に開発されてきました。培養例を含めながらラインナップをご紹介します。
Training for Life Science Researchers
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: A Novel “Thaw and Go” Cell-based Model to Study SLC Transporters
  • Live at: Feb 24 2015 5:00 pm
  • Presented by: Na Li, Ph.D.
  • From:
Your email has been sent.
or close